Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
International Stem Cell Corporation is a biotech company specializing in pluripotent stem cell research and development. It creates proprietary human parthenogenetic stem cells for therapeutic applications, notably in neurodegenerative diseases like Parkinson’s. The company also develops research tools and consumer skin care products. Its core value lies in ethically derived, immune-matched stem cells aimed at regenerative medicine, drug discovery, and cosmetic markets.
This description was generated via AI from an annual report. Updated about 1 year ago.